Titan Pharmaceuticals (TTNP)

P/S ratio as of December 2025 (TTM): N/A

According to Titan Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.20. At the end of 2025 the company had a P/S ratio of N/A.

P/S ratio history for Titan Pharmaceuticals from 2001 to 2025

PS ratio at the end of each year

Year	P/S ratio	Change
2025	N/A
2024	N/A	-100%
2023	> 1000	3209.2%
2022	188	362.44%
2021	40.6	-71.97%
2020	145	1618.57%
2019	8.43	186.33%
2018	2.94	-97.75%
2017	131	2221.59%
2016	5.63	-89.44%
2015	53.3	282.3%
2014	13.9	172.01%
2013	5.13	-55.91%
2012	11.6	-30.14%
2011	16.6	138.23%
2010	6.99	-99.59%
2009	> 1000	105.56%
2008	829	-40.75%
2007	> 1000	-65.33%
2006	> 1000	672.28%
2005	523	-52.76%
2004	> 1000	326.52%
2003	259	1798.05%
2002	13.7	-76.96%
2001	59.3

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Vanda Pharmaceuticals VNDA	1.53	N/A	🇺🇸 USA
MediciNova MNOV	569	N/A	🇺🇸 USA
Celldex Therapeutics CLDX	749	N/A	🇺🇸 USA
Johnson & Johnson JNJ	5.29	N/A	🇺🇸 USA
Novartis NVS	4.53	N/A	🇨🇭 Switzerland
Repligen RGEN	13.2	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Titan Pharmaceuticals (TTNP)

P/S ratio as of December 2025 (TTM): N/A